UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 106

Sortiert nach

Cereblon is a direct protein target for immunomodulatory and antiproliferative activities of lenalidomide and pomalidomide

Leukemia, 2012-11, Vol.26 (11), p.2326-2335

2012

Volltextzugriff (PDF)

Absence of mutations in cereblon (CRBN) and DNA damage-binding protein 1 (DDB1) genes and significance for IMiD therapy

Leukemia, 2014-05, Vol.28 (5), p.1129-1131

2014

Volltextzugriff (PDF)

Dexamethasone synergizes with lenalidomide to inhibit multiple myeloma tumor growth, but reduces lenalidomide-induced immunomodulation of T and NK cell function

Current cancer drug targets, 2010-03, Vol.10 (2), p.155

2010

Volltextzugriff (PDF)

CC‐99282 IS A NOVEL CEREBLON E3 LIGASE MODULATOR (CELMOD) AGENT WITH POTENT AND BROAD ANTITUMOR ACTIVITY IN PRECLINICAL MODELS OF DIFFUSE LARGE B‐CELL LYMPHOMA (DLBCL)

Hematological oncology, 2021-06, Vol.39 (S2)

2021

Volltextzugriff (PDF)

Damage Tolerance Protein Mus81 Associates with the FHA1 Domain of Checkpoint Kinase Cds1

Molecular and Cellular Biology, 2000-12, Vol.20 (23), p.8758-8766

2000

Volltextzugriff (PDF)

338 CC-223, a Selective mTOR Kinase Inhibitor, Potently Inhibits Proliferation of a Large Panel of Cancer Cell Lines in Vitro

European journal of cancer (1990), 2012-11, Vol.48, p.103-103

2012

Volltextzugriff (PDF)

Interaction of Cdc2 and Cdc18 with a fission yeast ORC2-like protein

Nature (London), 1996-01, Vol.379 (6563), p.360-363

1996

Volltextzugriff (PDF)

Pain relief by applying transcutaneous electrical nerve stimulation (TENS) during unsedated colonoscopy: A randomized double-blind placebo-controlled trial

European journal of pain, 2011-01, Vol.15 (1), p.29-35

2011

Volltextzugriff (PDF)

Nuclear localization of Cdc25 is regulated by DNA damage and a 14-3-3 protein

Nature (London), 1999-01, Vol.397 (6715), p.172-175

1999

Volltextzugriff (PDF)

Serine-345 is Required for Rad3-Dependent Phosphorylation and Function of Checkpoint Kinase Chk1 in Fission Yeast

Proceedings of the National Academy of Sciences - PNAS, 2001-09, Vol.98 (20), p.11289-11294

2001

Volltextzugriff (PDF)

Nuclear exclusion of Cdc25 is not required for the DNA damage checkpoint in fission yeast

Current biology, 2001-01, Vol.11 (1), p.50-54

2001

Volltextzugriff (PDF)

Replication Checkpoint Kinase Cds1 Regulates Recombinational Repair Protein Rad60

Molecular and Cellular Biology, 2003-08, Vol.23 (16), p.5939-5946

2003

Volltextzugriff (PDF)

Negative regulation of Cdc18 DNA replication protein by Cdc2

Molecular biology of the cell, 1998-01, Vol.9 (1), p.63-73

1998

Volltextzugriff (PDF)

Regulation of mitotic inhibitor Mik1 helps to enforce the DNA damage checkpoint

Molecular biology of the cell, 2000-01, Vol.11 (1), p.1-11

2000

Volltextzugriff (PDF)

DNA damage checkpoint control of mitosis in fission yeast

Cold Spring Harbor Symposia on Quantitative Biology, 2000, Vol.65, p.353

2000

Volltextzugriff (PDF)

Absence of mutations in cereblon genes and significance for IMiD therapy

Leukemia, 2014-05, Vol.28 (5), p.1129

2014

Volltextzugriff (PDF)

Calmodulin Regulates the Expression of CDKS, Cyclins and Replicative Enzymes During Proliferative Activation of Human T Lymphocytes

Biochemical and biophysical research communications, 1994-04, Vol.200 (1), p.306-312

1994

Volltextzugriff (PDF)

Calmodulin regulates DNA polymerase α activity during proliferative activation of NRK cells

Biochemical and biophysical research communications, 1992-05, Vol.184 (3), p.1517-1523

1992

Volltextzugriff (PDF)

Addition of calmodulin antagonists to NRK cells during G1 inhibits proliferating cell nuclear antigen expression

Cell calcium (Edinburgh), 1995-07, Vol.18 (1), p.30-40

1995

Volltextzugriff (PDF)

Erratum: Cereblon is a direct protein target for immunomodulatory and antiproliferative activities of lenalidomide and pomalidomide

Leukemia, 2012-11, Vol.26 (11), p.2445-2445

2012

Volltextzugriff (PDF)

Cereblon is a direct protein target for immunomodulatory and antiproliferative activities of lenalidomide and pomalidomide

Leukemia, 2012-11, Vol.26 (11), p.2445-2445

2012

Volltextzugriff (PDF)

B311 Lenalidomide Treatment Interferes with Ras/MAPK Activation and Induces Apoptosis in Multiple Myeloma

Clinical lymphoma & myeloma, 2009-02, Vol.9, p.S123-S123

2009

Volltextzugriff (PDF)

Protein kinase C regulates calmodulin expression in NRK cells activated to proliferate from quiescence

Cell calcium (Edinburgh), 1994-12, Vol.16 (6), p.446-454

1994

Volltextzugriff (PDF)

B309 Lenalidomide Inhibits the Multiple Myeloma Cell Survival Factor IRF4/MUM1

Clinical lymphoma & myeloma, 2009-02, Vol.9, p.S122-S122

2009

Volltextzugriff (PDF)

1 – 25 von 106

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(104)
Mit Volltextzugriff
(94)

Publikationsform

Artikel
(105)
Dissertationen
(1)

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(52)
Life Sciences & Biomedicine
(44)
Humans
(29)
Animals
(15)
Biological And Medical Sciences
(12)
Thalidomide - Analogs & Derivatives
(12)
Biochemistry & Molecular Biology
(11)
Genes
(10)
Cell Biology
(9)
Genomes
(9)
Hematology
(9)
Proteins
(9)
Thalidomide - Pharmacology
(9)
Antineoplastic Agents - Pharmacology
(8)
Chromosomes
(8)
Male
(8)
Multidisciplinary Sciences
(8)
Science & Technology - Other Topics
(8)
Cell Line, Tumor
(7)
Female
(7)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Blood
(32)
Nature
(7)
Cancer Research
(5)
Leukemia
(5)
Biochemical And Biophysical Research Communications
(3)
British Journal Of Haematology
(3)
Plant Physiology
(3)
Cell
(2)
Cell Calcium
(2)
Clinical Lymphoma & Myeloma
(2)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Cereblon is a direct protein target for immunomodulatory and antiproliferative activities of lenalidomide and pomalidomide

Absence of mutations in cereblon (CRBN) and DNA damage-binding protein 1 (DDB1) genes and significance for IMiD therapy

Dexamethasone synergizes with lenalidomide to inhibit multiple myeloma tumor growth, but reduces lenalidomide-induced immunomodulation of T and NK cell function

CC‐99282 IS A NOVEL CEREBLON E3 LIGASE MODULATOR (CELMOD) AGENT WITH POTENT AND BROAD ANTITUMOR ACTIVITY IN PRECLINICAL MODELS OF DIFFUSE LARGE B‐CELL LYMPHOMA (DLBCL)

Damage Tolerance Protein Mus81 Associates with the FHA1 Domain of Checkpoint Kinase Cds1

338 CC-223, a Selective mTOR Kinase Inhibitor, Potently Inhibits Proliferation of a Large Panel of Cancer Cell Lines in Vitro

Triggering interferon signaling in T cells with avadomide sensitizes CLL to anti-PD-L1/PD-1 immunotherapy

Interaction of Cdc2 and Cdc18 with a fission yeast ORC2-like protein

Pain relief by applying transcutaneous electrical nerve stimulation (TENS) during unsedated colonoscopy: A randomized double-blind placebo-controlled trial

Nuclear localization of Cdc25 is regulated by DNA damage and a 14-3-3 protein

Serine-345 is Required for Rad3-Dependent Phosphorylation and Function of Checkpoint Kinase Chk1 in Fission Yeast

Nuclear exclusion of Cdc25 is not required for the DNA damage checkpoint in fission yeast

Replication Checkpoint Kinase Cds1 Regulates Recombinational Repair Protein Rad60

Negative regulation of Cdc18 DNA replication protein by Cdc2

Regulation of mitotic inhibitor Mik1 helps to enforce the DNA damage checkpoint

DNA damage checkpoint control of mitosis in fission yeast

Absence of mutations in cereblon genes and significance for IMiD therapy

Calmodulin Regulates the Expression of CDKS, Cyclins and Replicative Enzymes During Proliferative Activation of Human T Lymphocytes

Calmodulin regulates DNA polymerase α activity during proliferative activation of NRK cells

Addition of calmodulin antagonists to NRK cells during G1 inhibits proliferating cell nuclear antigen expression

Erratum: Cereblon is a direct protein target for immunomodulatory and antiproliferative activities of lenalidomide and pomalidomide

Cereblon is a direct protein target for immunomodulatory and antiproliferative activities of lenalidomide and pomalidomide

B311 Lenalidomide Treatment Interferes with Ras/MAPK Activation and Induces Apoptosis in Multiple Myeloma

Protein kinase C regulates calmodulin expression in NRK cells activated to proliferate from quiescence

B309 Lenalidomide Inhibits the Multiple Myeloma Cell Survival Factor IRF4/MUM1

Suchergebnisse filtern